MétaCan
Menu
Back to cohort
Record W2163229490 · doi:10.3201/eid1003.030702

Clinical Trials and Novel Pathogens: Lessons Learned from SARS

2004· article· en· W2163229490 on OpenAlexaff
Matthew Muller, Allison McGeer, Sharon E. Straus, Laura Hawryluck, Wayne L. Gold

Bibliographic record

VenueEmerging infectious diseases · 2004
Typearticle
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsUniversity Health NetworkUniversity of TorontoMount Sinai Hospital
Fundersnot available
KeywordsOutbreakClinical trialRibavirinMedicineIntensive care medicineRandomized controlled trialVirologyPathologyVirus

Abstract

fetched live from OpenAlex

During the recent global outbreak of severe acute respiratory syndrome (SARS), thousands of patients received treatments of uncertain efficacy and known toxicity such as ribavirin and corticosteroids. Despite this, no controlled clinical trials assessing the efficacy of these agents were conducted. If a second global SARS outbreak occurred, clinicians would not have controlled data on which to base therapeutic decisions. We discuss the unique methodologic and logistical challenges faced by researchers who attempt to conduct controlled trials of therapeutic agents during an outbreak of a novel or unknown infectious pathogen. We draw upon our own experience in attempting to conduct a randomized controlled trial (trial) of ribavirin therapy for SARS and discuss the lessons learned. Strategies to facilitate future clinical trials during outbreaks of unknown or novel pathogens are also presented.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.248
metaresearch head score (Gemma)0.360
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.248
Threshold uncertainty score0.927

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2480.360
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0070.004
Bibliometrics0.0040.004
Science and technology studies0.0020.018
Scholarly communication0.0110.019
Open science0.0050.005
Research integrity0.0190.026
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.199
GPT teacher head0.475
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations36
Published2004
Admission routes1
Has abstractyes

Explore more

Same venueEmerging infectious diseasesSame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207